Description
Provider of a medical research and development services intended to offer large-scale cell culture manufacturing facilities. The company's medical research and development services offers a site for the production of monoclonal antibodies and recombinant proteins, enabling its clients to receive treatment related to large-scale cell culture.
Contact Information
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
3. Merger/Acquisition | 27-Aug-2008 | $6.48M | 000.00 | Completed | Generating Revenue | |
2. Early Stage VC | Completed | Generating Revenue | ||||
1. Joint Venture | 01-Jan-2007 | Completed | Generating Revenue |
Name | Representing | Role | Since |
---|---|---|---|
Stephan Kutzer Ph.D | Self | Chairman | 000 0000 |